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Abstract
Aims: Chemotherapy is frequently used as a conditioning regimen to destroy malignant marrow cells before 
transplantation. Xerostomia, dysphagia, altered taste perception, mucositis, soft-tissue ulceration, and infection are 
common adverse oral effects of chemotherapy. The study was aimed to compare decayed, missing, filled teeth (DMFT) 
scores before and after hematopoietic stem cell transplantation (HSCT) and chemotherapy.
Materials and Methods: Thirty-six patients undergoing HSCT were included in the study. A pre-HSCT dental treatment 
protocol was implemented that consisted of restoration of all active carious lesions, treatment of periodontal infections, 
and extraction of all teeth with advanced periodontal disease. Upon completion of dental treatment, the importance of 
rigorous and effective oral hygiene was reemphasized, and patients were recalled 6 months later. DMFT scores were 
calculated prior to the initiation of HSCT treatment and 6 months after transplantation.
Statistical Analysis Used: Regression analysis was used to evaluate the effects of HSCT and chemotherapy on DMFT scores.
Results: Wilcoxon T test showed a statistically significant difference in DMFT scores before and after HSCT (P < 0.001).
Conclusions: DMFT scores were found to increase after chemotherapy and HSCT, suggesting that the risk of infection 
is higher among HSCT patients when compared to other individuals. The results emphasize the need for dental 
examinations as an integral part of examination and treatment planning for patients undergoing HSCT and chemotherapy.
Key words: Chemotherapy, decayed missing filled teeth scores, hematopoietic stem cell transplantation
Date of Acceptance: 19-Feb-2013
Address for correspondence: 
Elif Tarım Ertas  
Department of Oral and Maxillofacial Radiology Faculty of Dentistry, 
Izmir Katip Celebi University, İzmir, Turkey. 
E-mail: dteliftarim@yahoo.com Tel: +90-352- 437 4901 /29125 
Introduction
Hematopoietic stem cell transplantation (HSCT) is a curative 
treatment option for many hematological malignancies; 
including lymphomas, acute and chronic leukemias, aplastic 
anemia, multiple myeloma, neuroblastoma, some solid 
tumors, severe combined immunodeficiency, inherited 
immune disorders, and myelodysplastic syndromes.[1‑5]
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Chemotherapy with or without total body irradiation is 
frequently used to destroy malignant marrow cells prior 
to transplantation. These cytoreductive regimens used 
for immunosuppression rapidly destroy dividing cell 
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decayed, missing, or filled. ‘DMF’ (referred to as ‘dmf’ in 
primary teeth) may be recorded in terms of either affected 
teeth (‘DMFT’) or affected tooth surfaces (‘DMFS’).[14] 
This study aimed to compare pre‑ and posttreatment dental 
status of patients undergoing HSCT and chemotherapy by 
examining their pre‑ and posttreatment DMFT scores.
Materials and Methods
This study was conducted with 36 patients (27 male, 
9 female) undergoing HSCT who were referred to our 
clinic at the Department of Oral Diagnosis and Radiology 
over a 2‑year period for pre‑and posttransplantation dental 
evaluations and oral health management. The ethical 
committee of our faculty gave approval for the study and 
Declaration of Helsinki have read and the guidelines 
followed in this investigation.
Pretransplantation evaluation included both clinical 
and radiographic examinations with appropriate ethical 
committee was obtained prior to the start of the study 
and that subjects were volunteers who had given 
informed, written consent. Oral hard and soft tissues were 
assessed, and dental characteristics (number of decayed, 
filled and missing teeth; impacted and semi‑impacted 
third molars; periapical and periodontal infection; retained 
roots) were recorded. Panoramic radiographs were taken 
of all patients, and in cases where suspicious periapical 
lesions were identified or superposition of contact surfaces 
occurred, either bitewing or periapical radiographs were 
also taken. Oral hygiene status was assessed through use of 
plaque index, as described by Löe and Silness.[15] Clinical 
and radiographic findings of periodontal disease, erupting 
third molars, unerupted third molars covered by soft tissue 
only, periapical radiolucency, retained root fragments with 
existing infection, deep dental caries more than half of the 
distance from the enamel to the pulp chamber, caries under 
restorations, and periodontal breakdown were considered 
to be potential foci of infection.
The CDC’s Guideline for Preventing Opportunistic 
Infection Among Hematopoietic Stem Cell Transplantation 
Recipent[16] recommends maintaining oral health, 
removing lesions that can easily lead to dental infections, 
extracting teeth affected by moderate or severe periodontal 
disease, and removing dentures and orthodontic 
appliances during cancer treatment.[16] According to 
the guidelines, a pre‑chemotherapy and HSCT dental 
treatment protocol was followed that included restoration 
of all active carious lesions, treatment of periodontal 
infections, and extraction of all teeth with advanced 
periodontal disease. As the first and most important step 
of the treatment protocol, medical consultation with the 
patient’s hematologist was conducted in order to establish 
the degree of immunosuppression and antibiotic coverage 
populations, particularly hematopoietic progenitor cells and 
mucosal epithelial cells. At the same time, the agents used 
in chemotherapy may destroy metabolically active normal 
tissue cells; thereby adversely affecting the kidneys, heart, 
skin, immune system, and gastrointestinal track; including 
the oral cavity. The constant exposure of oral tissue to 
physical, chemical, thermal, and microbial injury makes 
the mouth a primary site of complications associated with 
chemotherapy.[6] The most common adverse oral effects 
include xerostomia, dysphagia, altered taste perception, 
mucositis, soft‑tissue ulceration, and infection as well as 
gingivitis due to secondary pancytopenia associated with 
drug‑induced myelosuppression. Xerostomia may lead to 
increased plaque accumulation and lower the pH of residual 
saliva,[7] increasing susceptibility to dental caries and thus 
requiring extensive preventive care.[6]
Because patients undergoing chemotherapy and HSCT 
have an increased susceptibility to infection during and 
after transplantation, it is important to eradicate all sources 
of infection prior to treatment.[3,8] Together with the entire 
gastrointestinal tract (GIT), the oral cavity is an important 
point of entry for systemic infection, mainly by gram‑positive 
anaerobic microorganisms which can cause apical lesions 
and periodontal diseases.[9,10] Dental caries is an infectious 
microbiologic disease of the teeth that results in localized 
dissolution and destruction of calcified tissue. Dental caries 
and periodontal disease are probably the most common 
chronic diseases in the world.
Preexisting dental conditions may cause local and systemic 
complications during medical treatment.[11] Local dental 
infections that may remain inactive in healthy individuals 
can cause serious systemic complications in severely 
immunocompromised hosts as well as in patients undergoing 
HSCT.[3,12] Although new advances have been made in 
all areas of supportive care;[1] oral complications such as 
gingivitis, severe mucositis, and ulcerations continue to 
remain important causes of morbidity and mortality when 
not properly treated.[3]
Studies have reported that 29‑72% of patients undergoing 
HSCT had at least one oral infection that required treatment 
before transplantation.[9,12,13] In order to identify and treat 
all potential sources of infection, dental evaluation of 
patients prior to HSCT has become routine. One previous 
study reported that early dental intervention significantly 
reduced the incidence of oral complications associated with 
immunosuppression regimens from approximately 40 to 12%.[3] 
Given their key role in the diagnosis, prevention, and treatment 
of complications stemming from the oral cavity, dentists should 
be included on the treatment team from pretransplantation 
through recovery of immune competence.[1]
The most common epidemiologic measure of caries is an 
evaluation of the number of permanent teeth that are 
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required to prevent any oral or generalized infection 
and hemorrhage. Prophylactic treatment, including 
periodontal scaling and root planning, was performed 
as necessary, and periodontally questionable or hopeless 
teeth were extracted. Semi‑retained third molars and 
infected root fragments were also extracted, and faulty 
dental restorations were replaced, repaired, or if necessary, 
extracted so as to avoid any potential soft‑tissue irritation 
or periapical infection during the course of HSCT therapy. 
To ensure adequate wound healing, all extractions were 
performed at least 1 week before initiation of therapy. To 
as great extents as possible, extractions were atraumatic, 
and care was taken to reduce sharp ledges and achieve 
maximal soft‑tissue closure. Retained roots and fully 
impacted teeth with no clinical or radiological symptoms 
were left in place. In view of the prolonged healing 
period for 2 weeks[11] and extensive oral hygiene regime 
required during healing, no elective periodontal surgery 
was performed. Upon completion of dental treatment, 
the importance of rigorous and effective oral hygiene, 
including the use of fluoride‑containing toothpaste and 
mouthrinse, was reemphasized, and the patient was 
recalled 6 months later.
Following 6 months of chemotherapy and HSCT therapy, 
patients were again referred to our clinic for detailed 
clinical and radiographic examinations. In order to 
evaluate the effects of HSCT and chemotherapy on dental 
status, DMFT indexes were calculated before and after 
transplantation, and DMFT scores were compared using 
Wilcoxon T test.
Results
A total of 36 patients (27 male, 9 female) whose diagnoses 
included acute myelogenous leukemia (19 patients), 
acute lymphocytic leukemia (5 patients), aplastic 
anemia (4 patients), and various other conditions (9 patients) 
undergoing HSCT were examined for the study. Thirty‑four 
patients were treated with allogeneic SCT, and the remaining 
two patients were treated with autologous transplantation. 
Mean patient age was 32 years (mean age: 31.8 ± 12.4).
Distribution of the patients included in the study and the 
DMFT scores pre and posttreatment is given in Table 1. 
Overall pre‑ and posttransplantation mean DMFT scores 
were 7.0 and 8.83, respectively. While the median score of 
DMFT was 29.00 (26.00‑30.75) before transplantation, it 
was found to be 28.00 (24.25‑29.00) after HSCT. Wilcoxon 
T test showed the decrease in DMFT scores following HSCT 
to be statistically significant (P < 0.001).
Whereas at least one potential dental focus of infection 
was identified either radiographically or clinically in 34 of 
36 patients and treated prior to HSCT and chemotherapy, 
dental foci of infection were found in only 29 of 36 patients 
following 6 months after HSCT and chemotherapy. No 
correlation was found between dental status and age, sex, 
or underlying disease.
Gingival inflammation caused by dental plaque was recorded 
in 80% of the patients prior to chemotherapy and HSCT. 
Postchemotherapy and HSCT examination gingivitis was 
found in 69.4% of the patients, despite patient counselling 
on the importance of oral hygiene and the elimination of 
preexisting oral pathosis to the greatest extent possible. Prior 
to chemotherapy and HSCT, 4 of 31 impacted third molars, 
6 of 10 semi‑impacted third molars, and 6 of 13 retained 
root fragments were extracted due to existing infection or 
the risk of infection.
Pre‑ and posttransplantation D‑M‑F components are 
given in Table 2 separately. Of the 80 teeth with active 
carious lesions, 54 of them were restored ideally and 26 of 
them extracted due to advanced caries lesions extending 
more than half of the distance of enamel to pulp chamber. 
Besides, 14 teeth were also extracted because of periodontal 
problems. The percentage of decayed teeth was 7.9% prior 
to HSCT and chemotherapy and it increased to 8.9% 
following treatment. In terms of number of individuals, 
the number of decayed teeth was found to have increased 
in 22.2% patients.
Table 1: Distribution of the patients included in the study and the DMFT scores pre and post treatment
Diseases Patients (n (%)) Pre‑DMFT scores (median) DMFT scores after 6 months (median)
Acute myelogenous leukemia 19 (52.8) 7.0 8.0
Aplastic anemia 4 (10.3) 7.0 7.5
Myelodysplastic syndrome 1 (2.8) 3.0 19.0
Acute lymphocytic leukemia 5 (13.9) 5.0 8.0
NK cell lymphoma 1 (2.8) 11.0 12.0
Myelofibrosis 1 (2.8) 4.0 4.0
Multiple myeloma 3 (8.3) 9.0 14.0
B cell lymphoma 1 (2.8) 3.0 9.0
Lenfoblastic lymphoma 1 (2.8) 4.0 4.0
Total 36 (100.0) 5.0 8.0 (P<0.001)
DMFT=Decayed, missing, filled teeth; Nk=Neutral killer
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Discussion
Significant progress in medical management of cancer 
patients has been reported in recent years.[7,17] Improvements 
in diagnostic techniques and emphasis on early cancer 
detection have led to an increase in posttreatment life 
expectancy. As a result, it has become more common for 
dentists to treat patients who are currently undergoing or 
who have previously undergone treatment for cancer.[7] 
Treatment options for cancer patients include chemotherapy, 
radiotherapy, HSCT, surgical excision, or a combination of 
these procedures. Ideally, a dentist should be consulted for 
dental management before the initiation of cancer therapy, 
since good oral health is considered to be one of the most 
important components in improving mortality and morbidity 
rates. The optimal goal is to eliminate any potential dental 
focus of infection before cancer therapy begins and to 
maintain dental health during and after treatment.[18]
The oral cavity has been well documented as a source 
of septicemia in leukemia patients.[19,20] Rates of HSCT 
recipients with at least one oral infection that required 
treatment prior to transplantation have been reported to 
range from 29‑72%.[9,12,13] In our study, 34 of the 36 patients 
had at least one potential focus of infection prior to HSCT.
HSCT patients are usually pancytopenic before and 
immediately after transplantation and neutropenic for 
6‑12 months after engraftment.[21] During this time, oral 
infection may result in severe consequences. In view of the 
serious consequences of bacteremia and septicemia, it is 
widely accepted that a pre‑HSCT dental evaluation should 
be conducted, including both clinical and radiographical 
examination, a complete medical and dental history, 
evaluation of the patient’s level of oral hygiene and dental 
awareness, an assessment of the patient’s motivation, and 
ability to perform effective oral hygiene measures.[22] In line 
with the recommendations of CDC’s Guideline for Preventing 
Opportunistic Infection Among Hematopoietic Stem Cell 
Transplantation Recipients,[16] the patients in our study 
underwent detailed clinical and radiographic evaluation, 
including orthopantomographs and, if necessary, bitewing and 
periapical radiographs. Baseline dental and periodontal health 
was recorded, and any existing oral pathosis was eliminated 
to the greatest extent possible. Our dental treatment protocol 
included restoration of all active carious lesions, treatment 
of periodontal infections and extraction of any teeth with 
advanced periodontal disease or periapical infection, 
semi‑retained third molars, and teeth with infected root 
fragments. Retained roots and fully impacted teeth with no 
clinical or radiological symptoms were left in place. Patients 
were also instructed in oral hygiene techniques, including 
tooth brushing and flossing, and advised to use antimicrobial 
mouth rinse. Moreover, nutritional counseling was provided 
in order to help reduce the likelihood of dental caries and 
soft‑tissue trauma and minimize the adverse side effects of any 
xerostomia that might result from HSCT therapy.[22]
In the present study, the DMFT index was used to evaluate 
the effects of HSCT on dental status. The DMFT is a 
cumulative index that includes the number of teeth with 
active caries (‘D’), that is, bacterial infection, as well as the 
number of extractions (‘M’) and restorations (‘F’), which are 
presumed to represent teeth that were at some point affected 
by dental caries. It is important to distinguish between the 
DMFT’s ‘M’ and ‘F’ components, which are historical markers 
of the presence of past disease, and the ‘D’ component, which 
represents active disease, and to keep in mind that DMF rates 
do not provide a true measure of caries prevalence, but in 
fact, overestimate the prevalence of active caries.
Despite the counselling provided to patients in the present 
study regarding the importance of oral hygiene, DMFT 
scores increased significantly after HSCT treatment. It is 
possible that, patients ignored dental hygiene instructions 
and/or that the increase in DMFT scores was a result of 
xerostomia, one of the side effects of chemotherapy.
Studies have shown that oral and periodontal assessment 
and management reduce the risks of infection and fever 
associated with oral complications.[11,23,24] A study carried 
out by Melkos et al.,[3] with 58 patients, found a lower 
rate of complications among patients who received dental 
treatment before HSCT compared to those who did not 
receive dental treatment. In our study, the first step of the 
pre‑HSCT dental treatment protocol was to motivate and 
instruct patients (and their parents) in maintaining an 
appropriate level of oral hygiene. Instruction in oral hygiene 
consisted of more than simply telling patients to brush their 
teeth; rather, it included a demonstration of the specific 
type of toothbrush to be used, the method of brushing and 
flossing, and the areas to be reached.[25] All the patients 
are instructed to brush their teeth with fluoride toothpaste 
after each meal and at bedtime, along with flossing once a 
day. Besides, they are advised to clean their tongue gently 
with a toothbrush or tongue scraper in order to keep their 
mouth as clean as possible.
Leukocytopenia associated with cancer treatment may 
increase susceptibility to orogenic bacteremia, eventually 
causing sepsis and even death. Although many cancer 
therapy protocols recommend the cessation of all oral 
hygiene procedures during this period, several authorities 
state that the risk of plaque‑associated bacteremia requires 
Table 2: Distribution of the D‑M‑F components pre and 
posttreatment
D (n (%)) M (n (%)) F (n (%)) Total (n (%))
Pretreatment 80 (31.6) 133 (52.6) 40 (15.8) 253 (100.0)
Posttreatment 51 (16.0) 173 (54.4) 94 (29.6) 318 (100.0)
D‑M‑F=Decayed, missing, filled
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the continuation of gentle oral hygiene measures during 
therapy. This may include the wiping of teeth with cotton 
swabs or sponges and/or the use of brushing sticks dipped 
in an antimicrobial agent.[26,27]
For optimal transplantation management, appropriate 
patient selection must be accompanied by an optimal 
dental evaluation, pretreatment elimination of all 
infection sources, prompt management of complications 
during the immunosuppression period and regular 
posttransplantation follow‑up.[3,28‑31] In addition, gentle and 
frequent professional removal of dental plaque and calculus 
is often advised in order to maintain optimal oral hygiene 
and oral health. Long‑term oral sequelae such as rampant 
caries can be prevented by regular dental check‑ups, 
fluoride regimens, and the encouragement of home care 
oral hygiene. The successful achievement of this preventive 
period depends, to a large extent, on the compliance of the 
patient. The most critical issue is to keep the oral cavity 
as clean as possible. In the literature, it is reported that 
mouth rinses are widely used as an adjunct to maintain 
oral hygiene.[23,32] Fluoridated mouth rinses with a fluoride 
concentration of 0.05% is optimal for regular use.[33] Also, 
xylitol, which is a naturally occurring, low calorie sugar 
substitute with anticariogenic properties, is advised for the 
patients since the ability of plaque to produce acids by the 
metabolism of sugars is reduced by xylitol. As an important 
point to decrease dental decays, the presence of fluoride or 
xylitol in the mouthrinse is contributed to the reduction 
of Streptococcus mutans in plaque.[34] The ultimate goals of 
all these efforts is to reduce the incidence and frequency 
of oral complications, improve patient comfort, and help 
reduce the overall cost of care.
Conclusions
This study found that DMFT scores increased following 
chemotherapy and HSCT, indicating that HSCT patients are 
at a higher risk of infection since the oral cavity can act as 
the site of origin for dissemination of pathogenic organisms 
to distant body sites, especially in immunocompromised 
hosts such as patients suffering from malignancies, diabetes, 
or rheumatoid arthritis; or having corticosteroid or other 
immunosuppressive treatment. Within the limitations of 
this preliminary study that was limited by a small number 
of subjects, our findings emphasize the need for dental 
examinations as an integral part of examination and treatment 
planning for patients undergoing HSCT and chemotherapy.
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